A detailed history of Trellis Wealth Advisors LLC transactions in Gossamer Bio, Inc. stock. As of the latest transaction made, Trellis Wealth Advisors LLC holds 10,000 shares of GOSS stock, worth $8,900. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,000
Previous 15,000 33.33%
Holding current value
$8,900
Previous $13.5 Million 27.01%
% of portfolio
0.0%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024

SELL
$0.79 - $1.25 $3,950 - $6,250
-5,000 Reduced 33.33%
10,000 $9.86 Million
Q2 2024

Jul 30, 2024

BUY
$0.51 - $1.27 $7,650 - $19,050
15,000 New
15,000 $13.5 Million

Others Institutions Holding GOSS

About Gossamer Bio, Inc.


  • Ticker GOSS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 93,954,000
  • Market Cap $83.6M
  • Description
  • Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...
More about GOSS
Track This Portfolio

Track Trellis Wealth Advisors LLC Portfolio

Follow Trellis Wealth Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trellis Wealth Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Trellis Wealth Advisors LLC with notifications on news.